Skip to product information
Tirzepatide
★★★★
★
4.7
·
200+ orders served
Tirzepatide is a synthetic dual incretin receptor agonist that simultaneously activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. Its unique dual-agonist profile makes it a highly valuable compound for researchers studying multi-pathway metabolic signalling, receptor pharmacology, and gut-brain axis modulation.
Available in 10mg, 20mg, 30mg and 40mg vials. Every batch is HPLC tested and independently verified to a minimum of 99% purity. Certificate of Analysis available on request.
Research applications include:
- Dual GIP/GLP-1 receptor agonism and binding kinetics studies
- Comparative research vs single-agonist GLP-1 compounds
- Insulin secretion and metabolic pathway modelling
- Gut-brain axis and appetite signalling research
- Pancreatic beta-cell function studies
Product specifications:
- Form: Lyophilised powder
- Purity: ≥99% (HPLC verified)
- Storage: −20°C, protected from light and moisture
- Available sizes: 10mg · 20mg · 30mg · 40mg
- Origin: UK warehouse, same day dispatch
✓
Multibuy Discount Available
Buy 2 save 5%
Buy 3 save 10%
Buy 4 save 15%
Buy 5+ save 20%
£50.00
Sale price
£50.00
Regular price
£70.00
✓ 99%+ Purity Guaranteed
✓ COA Available
✓ Same Day UK Dispatch
✓ Secure Checkout
⚠ For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. Must be handled by qualified professionals in a suitable laboratory environment. Not evaluated by the MHRA or any regulatory authority for therapeutic use. Read full disclaimer →